Literature DB >> 29949360

QSAR Modeling of ToxCast Assays Relevant to the Molecular Initiating Events of AOPs Leading to Hepatic Steatosis.

Domenico Gadaleta1, Serena Manganelli1, Alessandra Roncaglioni1, Cosimo Toma1, Emilio Benfenati1, Enrico Mombelli2.   

Abstract

Nonalcoholic hepatic steatosis is a worldwide epidemiological concern since it is among the most prominent hepatic diseases. Indeed, research in toxicology and epidemiology has gathered evidence that exposure to endocrine disruptors can perturb cellular homeostasis and cause this disease. Therefore, assessing the likelihood of a chemical to trigger hepatic steatosis is a matter of the utmost importance. However, systematic in vivo testing of all the chemicals humans are exposed to is not feasible for ethical and economical reasons. In this context, predicting the molecular initiating events (MIE) leading to hepatic steatosis by QSAR modeling is an issue of practical relevance in modern toxicology. In this article, we present QSAR models based on random forest classifiers and DRAGON molecular descriptors for the prediction of in vitro assays that are relevant to MIEs leading to hepatic steatosis. These assays were provided by the ToxCast program and proved to be predictive for the detection of chemical-induced steatosis. During the modeling process, special attention was paid to chemical and toxicological data curation. We adopted two modeling strategies (undersampling and balanced random forests) to develop robust QSAR models from unbalanced data sets. The two modeling approaches gave similar results in terms of predictivity, and most of the models satisfy a minimum percentage of correctly predicted chemicals equal to 75%. Finally, and most importantly, the developed models proved to be useful as an effective in silico screening test for hepatic steatosis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29949360     DOI: 10.1021/acs.jcim.8b00297

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  19 in total

1.  Undersampling: case studies of flaviviral inhibitory activities.

Authors:  Stephen J Barigye; José Manuel García de la Vega; Juan A Castillo-Garit
Journal:  J Comput Aided Mol Des       Date:  2019-11-26       Impact factor: 3.686

2.  Adverse Outcome Pathways as Versatile Tools in Liver Toxicity Testing.

Authors:  Emma Arnesdotter; Eva Gijbels; Bruna Dos Santos Rodrigues; Vânia Vilas-Boas; Mathieu Vinken
Journal:  Methods Mol Biol       Date:  2022

3.  Mechanism-driven modeling of chemical hepatotoxicity using structural alerts and an in vitro screening assay.

Authors:  Xuelian Jia; Xia Wen; Daniel P Russo; Lauren M Aleksunes; Hao Zhu
Journal:  J Hazard Mater       Date:  2022-05-20       Impact factor: 14.224

Review 4.  Artificial intelligence to deep learning: machine intelligence approach for drug discovery.

Authors:  Rohan Gupta; Devesh Srivastava; Mehar Sahu; Swati Tiwari; Rashmi K Ambasta; Pravir Kumar
Journal:  Mol Divers       Date:  2021-04-12       Impact factor: 3.364

5.  Integrative Strategy of Testing Systems for Identification of Endocrine Disruptors Inducing Metabolic Disorders-An Introduction to the OBERON Project.

Authors:  Karine Audouze; Denis Sarigiannis; Paloma Alonso-Magdalena; Celine Brochot; Maribel Casas; Martine Vrijheid; Patrick J Babin; Spyros Karakitsios; Xavier Coumoul; Robert Barouki
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

6.  SAR and QSAR modeling of a large collection of LD50 rat acute oral toxicity data.

Authors:  Domenico Gadaleta; Kristijan Vuković; Cosimo Toma; Giovanna J Lavado; Agnes L Karmaus; Kamel Mansouri; Nicole C Kleinstreuer; Emilio Benfenati; Alessandra Roncaglioni
Journal:  J Cheminform       Date:  2019-08-30       Impact factor: 5.514

7.  Mining Public Toxicogenomic Data Reveals Insights and Challenges in Delineating Liver Steatosis Adverse Outcome Pathways.

Authors:  Mohamed Diwan M AbdulHameed; Venkat R Pannala; Anders Wallqvist
Journal:  Front Genet       Date:  2019-10-18       Impact factor: 4.599

8.  KnowTox: pipeline and case study for confident prediction of potential toxic effects of compounds in early phases of development.

Authors:  Andrea Morger; Miriam Mathea; Janosch H Achenbach; Antje Wolf; Roland Buesen; Klaus-Juergen Schleifer; Robert Landsiedel; Andrea Volkamer
Journal:  J Cheminform       Date:  2020-04-14       Impact factor: 5.514

9.  Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience.

Authors:  M J Moné; G Pallocca; S E Escher; T Exner; M Herzler; S Hougaard Bennekou; H Kamp; E D Kroese; Marcel Leist; T Steger-Hartmann; B van de Water
Journal:  Arch Toxicol       Date:  2020-09-04       Impact factor: 5.153

10.  Use of QSAR Global Models and Molecular Docking for Developing New Inhibitors of c-src Tyrosine Kinase.

Authors:  Robert Ancuceanu; Bogdan Tamba; Cristina Silvia Stoicescu; Mihaela Dinu
Journal:  Int J Mol Sci       Date:  2019-12-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.